Caricamento...
Modeling the long-acting administration of anti-tuberculosis agents using PBPK – a proof of concept study
SETTING AND OBJECTIVE: Current anti-tuberculosis (TB) formulations necessitate uninterrupted treatment to cure TB, but are characterised by sub-optimal adherence, jeopardising therapeutic efficacy. Long-acting injectable (LAI) formulations or implants could address these associated issues. This stud...
Salvato in:
| Pubblicato in: | Int J Tuberc Lung Dis |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166436/ https://ncbi.nlm.nih.gov/pubmed/29991405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0515 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|